Characterization of the short isoform of Helios overexpressed in patients with T-cell malignancies
- PMID: 17297655
- PMCID: PMC11159431
- DOI: 10.1111/j.1349-7006.2006.00372.x
Characterization of the short isoform of Helios overexpressed in patients with T-cell malignancies
Abstract
In an earlier report, we demonstrated overexpression of a short isoform of Helios, Hel-5, which lacks three of four N-terminal zinc fingers, in patients with adult T-cell leukemia/lymphoma. Here, we characterized Hel-5 using immunoprecipitation, and gel shift and luciferase promoter assays, and found that Hel-5 lacks the repressor function observed with a full-length isoform of Helios. Moreover, Hel-5 associates with the full-length isoforms of the Ikaros gene family, Ikaros, Aiolos and Helios, and inhibits their DNA binding activity when present in excess, leading to dominant-negative effects on the full-length isoforms of the Ikaros gene family. Our results suggest a critical role for Helios in the mechanism of leukemogenesis.
Figures







References
-
- Georgopoulos K, Bigby M, Wang J‐H et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79: 143 – 56. - PubMed
-
- Winandy S, Wu P, Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995; 83: 289 – 99. - PubMed
-
- Wang J‐H, Nichogiannopoulou A, Wu L et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996; 5: 537 – 49. - PubMed
-
- Nakayama H, Ishimaru F, Avitahl N et al. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 1999; 59: 3931 – 4. - PubMed
-
- Nakase K, Ishimaru F, Avitahl N et al. Dominant‐negative isoform of Ikaros gene in patients with adult B‐cell acute lymphoblastic leukemia. Cancer Res 2000; 60: 4062 – 5. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical